These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23114022)

  • 1. Family history of venous thromboembolism (VTE) as a predictor for recurrent VTE in unprovoked VTE patients.
    Gauthier K; Kovacs MJ; Wells PS; Le Gal G; Rodger M;
    J Thromb Haemost; 2013 Jan; 11(1):200-3. PubMed ID: 23114022
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of family history of venous thromboembolism and thrombophilia as predictors of recurrence: a prospective follow-up study.
    Sundquist K; Sundquist J; Svensson PJ; Zöller B; Memon AA
    J Thromb Haemost; 2015 Dec; 13(12):2180-6. PubMed ID: 26407905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin generation and activated protein C resistance in the absence of factor V Leiden correlates with the risk of recurrent venous thromboembolism in women aged 18-65 years.
    Sonnevi K; Tchaikovski SN; Holmström M; Rosing J; Bremme K; Lärfars G
    Thromb Haemost; 2011 Nov; 106(5):901-7. PubMed ID: 21947267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of cancer after anticoagulation in patients with unprovoked venous thromboembolism: an observational cohort study.
    Eischer L; Kammer M; Traby L; Kyrle PA; Eichinger S
    J Thromb Haemost; 2017 Jul; 15(7):1368-1374. PubMed ID: 28407356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
    Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
    Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superficial vein thrombosis and recurrent venous thromboembolism: a pooled analysis of two observational studies.
    Galanaud JP; Bosson JL; Genty C; Presles E; Cucherat M; Sevestre MA; Quere I; Decousus H; Leizorovicz A
    J Thromb Haemost; 2012 Jun; 10(6):1004-11. PubMed ID: 22429908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum lipoprotein (a) levels in patients with first unprovoked venous thromboembolism is not associated with subsequent risk of recurrent VTE.
    Rodger MA; Le Gal G; Carrier M; Betancourt MT; Kahn SR; Wells PS; Anderson DA; Lacut K; Chagnon I; Solymoss S; Crowther M; Perrier A; White R; Vickars L; Ramsay T; Kovacs MJ
    Thromb Res; 2010 Sep; 126(3):222-6. PubMed ID: 20580413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term recurrence of venous thromboembolism after short-term treatment of symptomatic isolated distal deep vein thrombosis: A cohort study.
    Donadini MP; Dentali F; Pegoraro S; Pomero F; Brignone C; Guasti L; Steidl L; Ageno W
    Vasc Med; 2017 Dec; 22(6):518-524. PubMed ID: 28732457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal Protac-induced coagulation inhibition chromogenic assay results are associated with an increased risk of recurrent venous thromboembolism.
    Tripodi A; Legnani C; Lemma L; Cosmi B; Palareti G; Chantarangkul V; Mannucci PM
    J Thromb Thrombolysis; 2010 Aug; 30(2):215-9. PubMed ID: 20419336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.
    Kaatz S; Fu AC; AbuDagga A; LaMori J; Bookhart BK; Damaraju CV; Tan H; Schein J; Nutescu E
    Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study.
    Le Gal G; Kovacs MJ; Carrier M; Do K; Kahn SR; Wells PS; Anderson DA; Chagnon I; Solymoss S; Crowther M; Righini M; Lacut K; White RH; Vickars L; Rodger M
    Thromb Haemost; 2010 Sep; 104(3):498-503. PubMed ID: 20539910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study.
    Kyrle PA; Kammer M; Eischer L; Weltermann A; Minar E; Hirschl M; Heinze G; Eichinger S
    J Thromb Haemost; 2016 Dec; 14(12):2402-2409. PubMed ID: 27696701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists.
    Nagler M; Angelillo-Scherrer A; Méan M; Limacher A; Abbal C; Righini M; Beer JH; Osterwalder J; Frauchiger B; Aschwanden M; Matter CM; Kucher N; Cornuz J; Banyai M; Husmann M; Staub D; Mazzolai L; Hugli O; Rodondi N; Aujesky D
    J Thromb Haemost; 2017 Nov; 15(11):2165-2175. PubMed ID: 28834238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of fibrinogen plasma levels, the -455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis.
    Tiedje V; Dunkler D; Ay C; Horvath B; Quehenberger P; Pabinger M; Zielinski C; Pabinger I; Mannhalter C
    Thromb Haemost; 2011 Nov; 106(5):908-13. PubMed ID: 21901234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening and functional exploration of prothrombin Arg596 related mutations in Chinese venous thromboembolism patients.
    Wu X; Li L; Ding Q; Wang X; Wu F; Wu W
    J Clin Pathol; 2018 Jul; 71(7):614-619. PubMed ID: 29331940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. F11 is associated with recurrent VTE in women. A prospective cohort study.
    Bruzelius M; Ljungqvist M; Bottai M; Bergendal A; Strawbridge RJ; Holmström M; Silveira A; Kieler H; Hamsten A; Lärfars G; Odeberg J
    Thromb Haemost; 2016 Jan; 115(2):406-14. PubMed ID: 26423325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism.
    White RH; Chan WS; Zhou H; Ginsberg JS
    Thromb Haemost; 2008 Aug; 100(2):246-52. PubMed ID: 18690344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of thrombophilia on the long-term survival of patients with a history of venous thromboembolism.
    Reitter-Pfoertner S; Waldhoer T; Mayerhofer M; Eigenbauer E; Ay C; Mannhalter C; Kyrle PA; Pabinger I
    Thromb Haemost; 2013 Jan; 109(1):79-84. PubMed ID: 23178976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Family history of venous thromboembolism (VTE) and risk of recurrent hospitalization for VTE: a nationwide family study in Sweden.
    Zöller B; Ohlsson H; Sundquist J; Sundquist K
    J Thromb Haemost; 2014; 12(3):306-12. PubMed ID: 24382197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients - results from the Vienna Cancer And Thrombosis Study (CATS).
    Pabinger I; Ay C; Dunkler D; Thaler J; Reitter EM; Marosi C; Zielinski C; Mannhalter C
    J Thromb Haemost; 2015 Jan; 13(1):17-22. PubMed ID: 25381723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.